| 10:30 - 11:45 | EP Masterclass 1 | Hall 8B |
| 10:30 - 11:45 | Oral Abstracts 1 - Allied and Service Development | Hall 11A |
| 11:30 - 18:45 | EP Traces Course | Hall 7B |
| 12:15 - 13:30 | Masterclass Devices 1 - New Technologies; and the advantages it creates | Hall 8B |
| 12:15 - 13:30 | Oral Abstracts 1 - Arrhythmia Clinical | Hall 11A |
| 14:45 - 16:15 | A-A Symposia - Sharing knowledge to optimise VT ablation outcomes in the UK | Hall 11A |
| 14:45 - 16:15 | AF Association Symposia - Restoring the Rhythm | Hall 8B |
| 14:45 - 16:15 | Nurses 1 | Hall 8A |
| 16:45 - 18:15 | A-A Symposia - Implantable cardiac devices | Hall 11A |
| 16:45 - 18:15 | AF Association Symposia - Is the future of DOAC's bright? | Hall 8B |
| Chair: Dr Manish Kalla | Birmingham, UK | |||
|---|---|---|---|---|
| 10:30 | The new UK AF ablation commissioning guidelines: will my patient be able to get an AF ablation? | Dr Joseph de Bono | Birmingham, UK | |
| 10:45 | Is PFA the holy grail of safe, reproducible AF ablation for the masses? | Prof Vivek Reddy | New York, US | |
| 11:00 | UNCOVER AF – where does dynamic mapping fit in with ablation strategy? | Dr Simon James | Middlesbrough, UK | |
| 11:15 | Will DEEP mapping bring optimised VT ablation results to all centres? | Dr Donah Zachariah | Cambridge, UK | |
| 11:30 | Q and A | |||
| 11:45 | Close |
| Chair: Prof Faizel Osman | Coventry, UK | |||
|---|---|---|---|---|
| 10:30 | DOES A PHYSIOLOGIST LED RESPONSE TO CARDIAC IMPLANTABLE ELECTRONIC DEVICE DETECTED HIGH-RATE ATRIAL EPISODES LEAD TO APPROPRIATE ANTICOAGULATION IN PRIMARY CARE? | Rebecca Warren | Newcastle Upon Tyne, UK | |
| 10:42 | A NEW MAGNETIC RESONANCE IMAGING (MRI) REFERRALS PLATFORM FOR PATIENTS WITH CARDIAC DEVICES | Bhavisha Patel | London, UK | |
| 10:54 | WARD-BASED IMPLANTABLE CARDIAC MONITOR INSERTION: TIME TO LEAVE THE CATHETER LAB? | Will Procter | London, UK | |
| 11:06 | THE NUH ALLIED HEALTH PROFESSIONAL ELECTIVE IMPLANTABLE LOOP RECORDER SERVICE. THE FIVE YEAR EXPERIENCE | Stuart Wildish | Nottingham, UK | |
| 11:18 | DETECTION PERFORMANCE OF THREE INSERTABLE CARDIAC MONITORS IN A SINGLE CENTER | Rebecca Macdonald | Worcester, UK | |
| 11:30 | UPGRADING TO CRT AT THE TIME OF EUR - A SINGLE-CENTRE RETROSPECTIVE STUDY TO EVALUATE THE IMPLEMENTATION OF A SPECIALIST CLINIC TO ASSESS PATIENTS FOR CARDIAC RESYNCHRONISATION THERAPY (CRT) DEVICES AT THE TIME OF ELECTIVE UNIT REPLACEMENT (EUR) | Marta Cunha | Cambridge, UK | |
| 11:42 | Closing remarks | |||
| 11:45 | Close |
| Chair: Dr Adam Graham, Dr Ruairidh Martin, Dr Simon Modi | Nottingham, UK, Newcastle Upon Tyne, UK, Liverpool, UK | |||
|---|---|---|---|---|
| 11:30 | Welcome, course objectives and ‘How to approach the unknown tracing’ | |||
| 11:45 | EP traces session 1 - 4 (please note there will be lunch, followed by 2 x breaks throughout the day) | |||
| 18:45 | Close |
| Chair: Dr Anoop Shetty, Ms Victoria Waites | London, UK, London, UK | |||
|---|---|---|---|---|
| 12:15 | Inequalities created by wearables | Mrs Rebecca Imms | Oxford, UK | |
| 12:30 | Improving communications; remote analysis messaging tools | Miss Nicole Campbell | London, UK | |
| 12:45 | Leadless Pacemakers | Dr Anoop Shetty | London, UK | |
| 13:00 | Live debate on the use of AI in cardiac rhythm management | |||
| For | Mr Christopher Redmond | London, UK | ||
| Against | Ms Victoria Waites | London, UK | ||
| 13:20 | Q and A | |||
| 13:30 | Close |
| Chair: Prof Tom Wong | London, UK | |||
|---|---|---|---|---|
| 12:15 | IMPACT OF INVESTIGATIONAL AT-HOME SELF-ADMINISTERED INTRANASAL ETRIPAMIL ON THE NEED FOR ADDITIONAL MEDICAL INTERVENTION IN PATIENTS WITH SUPRAVENTRICULAR TACHYCARDIA | Muhammad Sheikh | Charlotte, US | |
| 12:27 | QUANTIFICATION OF LEFT ATRIAL WALL THICKNESS BY CARDIAC COMPUTED TOMOGRAPHY IN PATIENTS WITH AND WITHOUT ATRIAL FIBRILLATION: IMPACT OF ESTIMATION METHOD | Johanna Tonko | London, UK | |
| 12:39 | EFFICACY OF COMBINING RANOLAZINE WITH A CLASS III ANTI-ARRHYTHMIC DRUG FOR MAINTAINING SINUS RHYTHM AFTER DC CARDIOVERSION | Sagarika Raman | Newcastle Upon Tyne, UK | |
| 12:51 | PERSISTENT ATRIAL FIBRILLATION CRYOBALLOON ABLATION SINGLE UK CENTRE EXPERIENCE (2015-2023) | Cho Thazin Aye | Plymouth, UK | |
| 13:03 | A COMPARISON OF ADMINISTRATION OF AJMALINE VIA INTRAVENOUS INJECTED BOLUSES VERSUS INTRAVENOUS INFUSION IN THE DIAGNOSIS OF BRUGADA SYNDROME | Sambhavi Sneha Kumar | Cambridge, UK | |
| 13:15 | IMPLEMENTING AN END-TO-END PATHWAY FOR DETECTION DIAGNOSIS AND MANAGEMENT OF ATRIAL FIBRILLATION IN THE RISK-STRATIFIED PATIENTS: RESULTS FROM THE ATRIAL FIBRILLATION STROKE PREVENTION HUB PROGRAM | Suma Kuriakose | Romford, UK | |
| 13:27 | Closing remarks | |||
| 13:30 | Close |
| Chair: Dr Justin Lee | Sheffield, UK | |||
|---|---|---|---|---|
| 14:45 | VT Voltage mapping - the Liverpool approach | Dr Vishal Luther | Liverpool, UK | |
| 15:05 | Let's simplify VT ablation - targeting the functional substrate | Dr Nick Linton | London, UK | |
| 15:25 | Novel Tools for Optimising VT Ablation: Going beyond Electroanatomical Mapping | Dr Shui Hao Chin | Leicester, UK | |
| 15:45 | Q and A | |||
| 16:15 | Close |
| Chair: Prof Natasja de Groot, Dr Vias Markides | Rotterdam, NL, London, UK | |||
|---|---|---|---|---|
| 14:45 | Beyond PVI in Ablating Persistent AF - What is the evidence? | Dr Vias Markides | London, UK | |
| 15:00 | Is PVI relevant in congenital heart disease? | Prof Natasja de Groot | Rotterdam, NL | |
| 15:15 | Restoring the rhythm in HFpEF - Is there any evidence? | Dr Rosita Zakeri | London, UK | |
| 15:30 | AF in HFrEF - Is restoration to sinus rhythm for everyone? | Prof Mark Petrie | Glasgow, UK | |
| 15:45 | PFA in AF ablation - What are the pit falls? | Prof Vivek Reddy | New York, US | |
| 16:00 | Q and A | |||
| 16:15 | Close |
| Chair: Mrs Kelly Anne Kinsella, Ms Shona Holding | Jersey, UK, Bradford, UK | |||
|---|---|---|---|---|
| 14:45 | AF Virtual Ward | Mrs Sue Armstrong | Leicester, UK | |
| 15:10 | Arrhythmia Nurse Competencies | Ms Ting Fang Feng | Watford, UK | |
| 15:35 | Q and A | |||
| 16:15 | Close |
| Chair: Dr Jenny Chuen, Dr Zachary Whinnett | Nottingham, UK, London, UK | |||
|---|---|---|---|---|
| 16:45 | Risks and benefits of ICD's in patients with end stage renal failure | Dr Giulia Domenichini | Lausanne, CH | |
| 17:05 | My approach to conduction system pacing implantation | Dr Badrinathan Chandrasekaran | Swindon, UK | |
| 17:25 | Update on clinical trials in conduction system pacing | Dr Nadine Ali | London, UK | |
| 17:45 | Q and A | |||
| 18:15 | Close |
| Chair: Dr Alexander Cohen, Prof John Camm | London, UK, London, UK | |||
|---|---|---|---|---|
| 16:45 | Does the diabetic patient benefit more from DOACs than VKAs | Prof John Camm | London, UK | |
| 17:05 | What is the evidence that DOACs can be used in severe renal failure | Dr Azmil Abdul-Rahim | Liverpool, UK | |
| 17:25 | Will Factor XI inhibitors take over from DOACs? | Dr Alexander Cohen | London, UK | |
| 17:45 | Integration of a Specialist pharmacist-led multidisciplinary team in primary care: Preventing strokes in people with atrial fibrillation across North East London | Mr Mital Patel | London, UK | |
| 18:00 | Q and A | |||
| 18:15 | Close |